1,412
Views
1
CrossRef citations to date
0
Altmetric
Original Research

T-cell dysfunction in natural killer/T-cell lymphoma

, , , , , , , & show all
Article: 2212532 | Received 20 Dec 2022, Accepted 08 May 2023, Published online: 24 May 2023
 

ABSTRACT

Natural killer/T-cell lymphoma (NKTCL) is an incurable aggressive T-cell lymphoma closely correlated with Epstein‒Barr virus (EBV) infection. Chronic and consistent viral infection induces T-cell exhaustion. Herein, we describe T-cell dysfunction in NKTCL patients for the first time. Peripheral blood mononuclear cells (PBMCs) from age-matched healthy donors (HDs) and NKTCL patients were collected, and lymphocyte distributions, multiple surface inhibitory receptors (IRs), effector cytokine production and cell proliferation were determined by flow cytometry. PBMCs from HDs were cocultured with NKTCL cell lines to verify the clinical findings. IR expression was further assessed in NKTCL tumor biopsies using multiplex immunohistochemistry (mIHC). NKTCL patients have higher frequencies than HDs of inhibitory T regulatory cells (Tregs) and myeloid-derived suppressor cells (MDSCs). T-cell distribution also varies between NKTCL patients and HDs. T cells from NKTCL patients demonstrated higher expression levels of multiple IRs than HDs. Meanwhile, T-cell proliferation and interferon-γ production was significantly reduced in NKTCL patients. More importantly, the number of EBV-specific cytotoxic cells was lower in NTKCL patients, and these cells demonstrated upregulation of multiple IRs and secreted fewer effector cytokines. Interestingly, NKTCL cells caused normal PBMCs to acquire T-cell exhaustion phenotypes and induced generation of Tregs and MDSCs. In line with ex vivo finding, mIHC results showed that CD8+ T cells from NKTCL tumor biopsies expressed much higher level of IRs compared with reactive lymphoid hyperplasia individuals. The immune microenvironment of NKTCL patients exhibited T-cell dysfunction and accumulation of inhibitory cell components, which may contribute to impaired antitumor immunity.

Acknowledgments

This work was supported by the National Natural Science Foundation of China (82000203 by XF, 81970184 by MZ, 82170183 by MZ, 82070210 by XZ) and Medical Science and Technology Project of Health Commission of Henan Province (LHJG20190203 by RD).

Disclosure statement

No potential conflict of interest was reported by the author(s).

Supplementary material

Supplemental data for this article can be accessed online at https://doi.org/10.1080/2162402X.2023.2212532.

Additional information

Funding

The work was supported by the National Natural Science Foundation of China [82000203]; National Natural Science Foundation of China [82070210]; National Natural Science Foundation of China [81970184]; National Natural Science Foundation of China [82170183]; Medical Science and Technology Project of Health Commission of Henan Province [LHJG20190203].